Support for ground-breaking brain tumour research
INTEGRA Biosciences is supporting vital translational research into diffuse intrinsic ponsglioma (DIPG) – a rare childhood brain tumour.
Dr Alexander Beck’s DIPG Fighter research group at the Ludwig Maximilian University of Munich (LMU) focuses on finding new therapies for DIPG, which usually affects children between five and nine years of age, with no significant long-term survival beyond five years.
The group routinely uses a range of INTEGRA products – including the ASSIST PLUS pipetting robot, VOYAGER adjustable tip spacing pipettes, EVOLVE manual pipettes and PIPETBOY acu 2 pipette controllers – and INTEGRA is delighted to be supporting this valuable work with this year’s festive donation, helping the rapid translation of research findings to the clinic.
Other News
Featured Supplier
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. We have one mission: to do now what patients need next.
Twenty nine medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them...
Upcoming Events
analytica 2022
Messe München, Germany
June 21-24, 2022
The Genomic and Microbiology Revolution: In Technology We Trust?
Royal Air Force Museum, Hendon, London
19 July 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
